US Development Finance Corporation (DFC) is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India, enabling BioE to ramp up to produce at least 1 billion COVID19 doses of vaccines by end of 2022: US NSA Sullivan to NSA Doval

— ANI (@ANI) April 25, 2021